Your browser doesn't support javascript.
loading
Rivaroxaban: is it Really Need to Monitor its Anticoagulant Effect in Clinical Practice?
Camanho, Luiz Eduardo Montenegro; Santos, Gustavo Vignoli dos.
Affiliation
  • Camanho, Luiz Eduardo Montenegro; Hospital Pró-Cardíaco. Rio de Janeiro. BR
  • Santos, Gustavo Vignoli dos; Hospital Pró-Cardíaco. Rio de Janeiro. BR
Int. j. cardiovasc. sci. (Impr.) ; 34(2): 122-123, Mar.-Apr. 2021.
Article in English | LILACS | ID: biblio-1154546
Responsible library: BR1.1
Subject(s)

Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: International databases Database: LILACS Main subject: Atrial Fibrillation / Thrombolytic Therapy / Rivaroxaban Language: English Journal: Int. j. cardiovasc. sci. (Impr.) Journal subject: Cardiology Year: 2021 Document type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital Pró-Cardíaco/BR
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: International databases Database: LILACS Main subject: Atrial Fibrillation / Thrombolytic Therapy / Rivaroxaban Language: English Journal: Int. j. cardiovasc. sci. (Impr.) Journal subject: Cardiology Year: 2021 Document type: Article Affiliation country: Brazil Institution/Affiliation country: Hospital Pró-Cardíaco/BR